Metal Artifact Reduction MRI of Total Ankle Arthroplasty

• Main Authors: Cesar Cesar Netto MD, Lucas F. Fonseca MD, Eric J. Dein BS, Hanci Zhang BA, Talal A. Zahoor MBBS, Lew C. Schon MD, Jan Fritz MD
• Format: Article
• Language: English
• Published: SAGE Publishing 2016-08-01
• Series: Foot & Ankle Orthopaedics
• Online Access: https://doi.org/10.1177/2473011416S00225

Category: Ankle Arthritis Introduction/Purpose: Total ankle arthroplasty (TAA) is an often successful treatment for end-stage ankle arthritis; however, a subset of patient presents with ankle pain following TAA and concern for early failure. Although radiographs are often diagnostic, patients with normal radiographs and continued pain pose a diagnostic challenge. In those patients, magnetic resonance imaging (MRI) may be helpful to evaluate periprosthetic bone and soft tissues. Traditional high-bandwidth (high-BW) metal artifact reduction sequence (MARS) MRI lessens metal artifacts, but image distortions remain with Cobalt-Chromium implants. Slice- Encoding-Metal-Artifact-Correction (SEMAC) is a recently FDA-approved, advanced MARS technique that promises more powerful metal suppression. Therefore, we prospectively tested the hypothesis that SEMAC MARS MRI facilitates better metal reduction and visibility of periprosthetic structures than does traditional MARS MRI in patients with TAA. Methods: In this IRB-approved study, 20 volunteers [10 females/10 males; age, 59 (41-73) years, 15 (3-24) months post- operatively] with TAA were prospectively enrolled. The research protocol consisted of high-BW and SEMAC MARS MRI using a clinical 1.5 Tesla MRI scanner and a dedicated boot-shaped MRI coil. For each technique, intermediate-weighted and fat- suppressed MR images were obtained in axial, sagittal and coronal orientation. Three observes (2 foot/ankle surgeons and 1 musculoskeletal radiologist) evaluated the high-BW and SEMAC MR images in an independent, random and blinded fashion. Equidistance 5-point Likert scales (1=non-diagnostic, 5=very good) were used to grade image quality as well as the quality of metal suppression and visibility of bone-metal interfaces, tendons, ligaments, bone and joints. Differences between the two MARS techniques were assessed with a Kruskall-Wallis test, and interobserver agreement was graded with Intraclass-Correlation- Coefficient (ICC). Bonferroni-corrected p-values ≤ 0.01 were considered significant. Results: All 20 subjects completed the research protocol. There was good agreement between observers (ICC = 0.79; 95% CI, 0.78-0.80). Image quality of high-BW and SEMAC MR images was similar for tissue contrast, fat suppression, and fluid brightness, whereas image sharpness was one interval higher on high-BW images than on SEMAC images (p < 0.01). Metal reduction of TAA components was significantly better (p < 0.01) on SEMAC images (very good) than on high-BW images (poor-to-adequate). At level of the implants, long flexor and peroneal tendons, deep deltoid, syndesmotic and lateral collateral ligaments, and medial and lateral gutters were significantly better seen (p < 0.01) on SEMAC images (good-to-very good) than on high-BW images (poor-to- adequate). Similar visibility (good-to-very good) was found for the remainder of the tendons, ligaments, bones and joints. Conclusion: Based on the results of our study, we accept the hypothesis that SEMAC MARS MRI outperforms traditional high- BW MARS MRI in the degree of metal artifact reduction as well as visibility of bone implant interfaces and periprosthetic tendons and ligaments at level of the joint line. We believe advanced MARS MRI can be a valuable clinical tool to assess osseous integration and soft tissue lesions in patients following TAA.